FAQ
Frequently asked questions
About Vibe Bio
Vibe Bio analyzes and invests in promising drug programs. Our drug analytic software, VibeOne, uses artificial intelligence (AI) to help pharmaceutical companies diligence drug R&D. Vibe Bio is advancing projects that currently are not getting the funding and attention they deserve.
We believe in the potential applications of decentralized and distributed science. One important component of DeSci is data accessibility. The VibeOne platform can provide data-driven insight solutions for our partners and we would love to partner with you.
We consider rare disease research and drug development incredibly important for both patients and researchers. One in ten Americans have a rare disease. By advancing the research needed for drug development, patients will benefit by having more life-changing therapies available to them.
Our mission is focused on finding every cure for every community. Vibe Bio helps biotechs by funding & guiding high-potential drug programs at critical inflection points. Our core is a community of scientists, patients, VCs, and biopharma thought leaders that are dedicated to helping you find the promising treatments that patients deserve.
You can reach out to us with your proposals for co-marketing activities, reciprocal thought-leadership, and investment opportunities. We are always eager to connect with patients, families, advocates, scientists, VCs, biopharma companies, and others who are as passionate as we are about financing treatments for overlooked diseases.
About AI analytics
VibeOne uses a variety of AI techniques, including machine learning, deep learning, and natural language processing. The software is able to learn from the data it analyzes and improve its accuracy over time.
The software analyzes large datasets of scientific data, including pre-clinical and clinical data, to identify patterns and trends that may not be visible to the human eye. This information can then be used to assess the risks and rewards of different drug projects, and to make more informed decisions about where to allocate resources.
When submitting program information to Vibe Bio for possible fund consideration, all information is stored privately, securely, and inaccessible to anyone but appropriately-credentialed Vibe employees.
At no point will your proprietary information ever be exposed or used to train publicly-available models. Vibe Bio’s own work product may be anonymized and aggregated for future benchmarking and reporting.
Vibe Bio’s AI software is not available for external use at this time. If you’re interested in leveraging our software and data platform or collaborating with us, please reach out.
About the fund
The software analyzes large datasets of scientific data, including pre-clinical and clinical data, to identify patterns and trends that may not be visible to the human eye. This information can then be used to assess the risks and rewards of different drug projects, and to make more informed decisions about where to allocate resources.
Our due diligence team considers an array of variables in order to make a decision based on scientific merit and clinical opportunity. Our mission to find every cure for every community empowers us to invest in a variety of therapeutic areas.
